- Home
- PII vs IMVT Comparison
PII vs IMVT Comparison
Compare PII & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PII
- IMVT
- Stock Information
- Founded
- PII 1954
- IMVT N/A
- Country
- PII United States
- IMVT United States
- Employees
- PII N/A
- IMVT N/A
- Industry
- PII Recreational Games/Products/Toys
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PII Consumer Discretionary
- IMVT Health Care
- Exchange
- PII Nasdaq
- IMVT Nasdaq
- Market Cap
- PII 3.8B
- IMVT 4.2B
- IPO Year
- PII 1987
- IMVT N/A
- Fundamental
- Price
- PII $60.00
- IMVT $26.94
- Analyst Decision
- PII Buy
- IMVT Strong Buy
- Analyst Count
- PII 12
- IMVT 11
- Target Price
- PII $85.00
- IMVT $48.10
- AVG Volume (30 Days)
- PII 814.1K
- IMVT 799.9K
- Earning Date
- PII 01-28-2025
- IMVT 02-10-2025
- Dividend Yield
- PII 4.38%
- IMVT N/A
- EPS Growth
- PII N/A
- IMVT N/A
- EPS
- PII 3.57
- IMVT N/A
- Revenue
- PII $7,803,200,000.00
- IMVT N/A
- Revenue This Year
- PII N/A
- IMVT N/A
- Revenue Next Year
- PII $1.03
- IMVT N/A
- P/E Ratio
- PII $17.04
- IMVT N/A
- Revenue Growth
- PII N/A
- IMVT N/A
- 52 Week Low
- PII $60.25
- IMVT $24.61
- 52 Week High
- PII $100.91
- IMVT $45.58
- Technical
- Relative Strength Index (RSI)
- PII 32.70
- IMVT 44.77
- Support Level
- PII $60.08
- IMVT $26.19
- Resistance Level
- PII $67.51
- IMVT $28.08
- Average True Range (ATR)
- PII 2.18
- IMVT 1.01
- MACD
- PII -0.27
- IMVT -0.03
- Stochastic Oscillator
- PII 11.59
- IMVT 32.73
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products retailed through more than 2,500 dealers in North America and through 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).